Q32 BIO INC (QTTB) Forecast, Price Target & Analyst Ratings

NASDAQ:QTTB • US7469641051

Current stock price

4.92 USD
-0.55 (-10.05%)
At close:
5.39 USD
+0.47 (+9.55%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for Q32 BIO INC (QTTB).

Forecast Snapshot

Consensus Price Target

Price Target
$14.62
+ 197.15% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 6, 2026
Period
Q1 / 2026
EPS Estimate
-$0.69
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.22%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$14.62
Upside
+ 197.15%
From current price of $4.92 to mean target of $14.62, Based on 9 analyst forecasts
Low
$10.10
Median
$13.26
High
$21.00

Price Target Revisions

1 Month
-4.44%
3 Months
26.47%

Price Target Summary

9 Wall Street analysts provided a forecast for the next 12 months for QTTB. The average price target is 14.62 USD. This implies a price increase of 197.15% is expected in the next year compared to the current price of 4.92.
The average price target has been revised upward by 26.47% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

QTTB Current Analyst RatingQTTB Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

QTTB Historical Analyst RatingsQTTB Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
82.22%
QTTB was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about QTTB.
In the previous month the buy percentage consensus was at a similar level.
QTTB was analyzed by 9 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-02-25HC Wainwright & Co.Initiate Buy
2025-03-12Wells FargoMaintains Equal-Weight -> Equal-Weight
2025-02-11BMO CapitalDowngrade Outperform -> Market Perform
2025-02-11Piper SandlerDowngrade Overweight -> Neutral
2024-12-12GuggenheimDowngrade Buy -> Neutral
2024-12-12BMO CapitalMaintains Outperform -> Outperform
2024-12-11Leerink PartnersDowngrade Outperform -> Market Perform
2024-12-11OppenheimerMaintains Outperform -> Outperform
2024-12-11Wells FargoDowngrade Overweight -> Equal-Weight
2024-12-11Raymond JamesDowngrade Strong Buy -> Outperform
2024-12-11Piper SandlerMaintains Overweight -> Overweight
2024-12-06BMO CapitalInitiate Outperform
2024-10-24Raymond JamesInitiate Strong Buy
2024-09-11Wells FargoInitiate Overweight
2024-06-17GuggenheimInitiate Buy
2024-05-21Leerink PartnersInitiate Outperform
2024-04-11OppenheimerInitiate Outperform
2024-04-02Piper SandlerInitiate Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 6, 2026
Period
Q1 / 2026
EPS Estimate
-$0.69
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
22.93%
Number of Analysts
4

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
23.60%
EPS (3 Months)
23.60%

Next Earnings Summary

QTTB is expected to report earnings on 5/6/2026. The consensus EPS estimate for the next earnings is -0.69 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2028

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
QTTB revenue by date.QTTB revenue by date.
1.156M
-63.99%
-100.00%		53.737M
-100.00%		680.003K
EBITDA
YoY % growth
QTTB ebitda by date.QTTB ebitda by date.
-91.524M
30.66%		-65.615M
28.31%		17.293M
126.36%		-41.718M
-341.24%		-49.368M
-18.34%		N/A
EBIT
YoY % growth
QTTB ebit by date.QTTB ebit by date.
-92.102M
30.90%		-66.102M
28.23%		16.902M
125.57%		-42.058M
-348.83%		-98.487M
-134.17%		-152.09M
-54.43%
Operating Margin
QTTB operating margin by date.QTTB operating margin by date.
-7,967.30%N/A31.45%N/AN/A-22,366.09%
EPS
YoY % growth
QTTB eps by date.QTTB eps by date.
-35.28
-3.16%		-18.99
46.17%		1.37
107.21%		-2.63
-291.79%		-4.09
-55.77%		N/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.69
22.93%		-0.39
50.31%		-0.40
33.70%		-0.42
-111.60%
Revenue
Q2Q % growth
-100.00%
EBITDA
Q2Q % growth		-8.262M
31.77%		-8.67M
3.25%		-9.078M
-24.77%		-9.588M
-120.72%
EBIT
Q2Q % growth		-11.22M
8.24%		-11.22M
-22.34%		-11.22M
-48.08%		-12.24M
-126.68%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

QTTB Yearly Revenue VS EstimatesQTTB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2025 2028 10M 20M 30M 40M 50M
QTTB Yearly EPS VS EstimatesQTTB Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -20 -40 -60 -80

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

Q32 BIO INC / QTTB Forecast FAQ

What do analysts expect the price target to be for Q32 BIO INC (QTTB)?

9 analysts have analysed QTTB and the average price target is 14.62 USD. This implies a price increase of 197.15% is expected in the next year compared to the current price of 4.92.

What is the next earnings date for QTTB stock?

Q32 BIO INC (QTTB) will report earnings on 2026-05-06.

Can you provide the consensus estimates for Q32 BIO INC next earnings?

The consensus EPS estimate for the next earnings of Q32 BIO INC (QTTB) is -0.69 USD and the consensus revenue estimate is 0 USD.

How do analysts rate Q32 BIO INC (QTTB)?

The consensus rating for Q32 BIO INC (QTTB) is 82.2222 / 100 . This indicates that analysts generally have a positive outlook on the stock.